Denali Capital Acquisition Corp. Files 2024 Annual Report
Ticker: SMNRW · Form: 10-K · Filed: Apr 2, 2025 · CIK: 1913577
| Field | Detail |
|---|---|
| Company | Denali Capital Acquisition Corp. (SMNRW) |
| Form Type | 10-K |
| Filed Date | Apr 2, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Denali Capital Acquisition Corp. filed its 2024 10-K. All systems go.
AI Summary
Denali Capital Acquisition Corp. filed its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, incorporated in the Cayman Islands with its principal executive offices in New York, NY, is involved in the Pharmaceutical Preparations industry. The filing was made on April 2, 2025, under SEC file number 001-41351.
Why It Matters
This 10-K filing provides a comprehensive overview of Denali Capital Acquisition Corp.'s financial performance and business operations for the fiscal year 2024, crucial for investors assessing the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a standard annual report filing for a publicly traded company, indicating routine business operations and disclosures.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- April 2, 2025 — Filing Date (The date the 10-K was submitted to the SEC.)
- 001-41351 — SEC File Number (Unique identifier for the company's filings.)
Key Players & Entities
- Denali Capital Acquisition Corp. (company) — Filer of the 10-K report
- 2024 (date) — Fiscal year end for the report
- April 2, 2025 (date) — Filing date of the report
- 001-41351 (dollar_amount) — SEC file number
- Cayman Islands (company) — State of incorporation
- New York, NY (company) — Location of principal executive offices
- Pharmaceutical Preparations (company) — Standard Industrial Classification
FAQ
What is the primary business of Denali Capital Acquisition Corp.?
Denali Capital Acquisition Corp. is classified under Standard Industrial Classification 2834, which pertains to Pharmaceutical Preparations.
When was this annual report filed with the SEC?
This Form 10-K was filed on April 2, 2025.
For which fiscal year is this report?
The report covers the fiscal year ended December 31, 2024.
Where are Denali Capital Acquisition Corp.'s principal executive offices located?
The principal executive offices are located at 437 Madison Avenue, 27th Floor, New York, New York, 10022.
What is the company's state of incorporation?
Denali Capital Acquisition Corp. is incorporated in the Cayman Islands.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 2, 2025 regarding Denali Capital Acquisition Corp. (SMNRW).